Feb 22, 2020 | Copay Accumulators, Copay Assistance, Drug Costs, Federal Issues, News
Patients struggling with the high cost of health insurance can expect even higher out-of-pocket costs in 2021, under an insurance regulation proposed by the Centers for Medicare & Medicaid Services. Last month, the obscure federal agency under the Department of...
Nov 11, 2019 | Drug Costs
What Is the 340B Drug Pricing Program? Established by Congress in 1992 and managed by the Health Resources and Services Administration (HRSA), the 340B Drug Pricing Program mandates drug manufacturers participating in Medicaid to provide certain outpatient drugs...
Sep 9, 2019 | Copay Accumulators, Drug Costs, News, Out of Pocket Costs
Get ready for higher out-of-pocket costs in 2020. Last week, the Trump administration’s Centers for Medicare & Medicaid Services quietly announced new co-pay rules that will allow insurance companies to increase patients’ out-of-pocket costs in 2020....
Aug 6, 2019 | Drug Costs, News
One of the few policy priorities that Democrats share with President Trump is reducing prescription drug prices. At his recent State of the Union address, Trump said he wants his administration “to make fixing the injustice of high drug prices one of our top...
Aug 6, 2019 | Drug Costs, News
Patricia Bernard of Falmouth has unwittingly become the face of American seniors facing high drug costs. Sen. Susan Collins recently invited Bernard to tell her story before the Senate Aging Committee, which Collins chairs. Diagnosed with rheumatoid arthritis 25 years...
Aug 6, 2019 | Drug Costs, Medicare Part D, News
Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
